Portal de Periódicos da CAPES

ESVM guidelines – the diagnosis and management of Raynaud’s phenomenon

2017; Hogrefe Verlag; Volume: 46; Issue: 6 Linguagem: Inglês

10.1024/0301-1526/a000661

1664-2872

J. J. F. Belch, Anita Carlizza, Patrick Carpentier, J. Constans, Faisel Khan, Jean-Claude Wautrecht, Adriana Visonà, Christian Heiß, Marianne Brodeman, Zsolt Pécsvarády, K Roztocĭl, Mary Paula Colgan, Dragan Vasić, Anders Gottsäter, Beatrice Amann‐Vesti, Ali Chraim, Pavel Poredoš, Dan Mircea Olinic, Juraj Maďarič, Sigrid Nikol, Ariane L. Herrick, Muriel Sprynger, Peter Klein-Weigel, Franz Hafner, Daniel Staub, Zan Zeman,

Dermatological and Skeletal Disorders

Abstract. Regarding the clinical diagnosis of Raynaud’s phenomenon and its associated conditions, investigations and treatment are substantial, and yet no international consensus has been published regarding the medical management of patients presenting with this condition. Most knowledge on this topic derives from epidemiological surveys and observational studies; few randomized studies are available, almost all relating to drug treatment, and thus these guidelines were developed as an expert consensus document to aid in the diagnosis and management of Raynaud’s phenomenon. This consensus document starts with a clarification about the definition and terminology of Raynaud’s phenomenon and covers the differential and aetiological diagnoses as well as the symptomatic treatment.